NCT07453680Completed
Comparative Effect of Myo-inositol With That of D-chiro-inositol on Insulin Resistance in Infertile Women With Polycystic Ovary Syndrome (PCOS).
Effect of Myo-inositol Compared to D-chiro-inositol on Insulin Resistance in Infertile Women With Polycystic Ovary Syndrome: A Non-inferiority Trial
Source: ClinicalTrials.gov · Last updated 6 Mar 2026
Brief summary (registry, in English)
This randomized controlled trial was conducted in the Department of Reproductive Endocrinology and Infertility, BSMMU.A total of 80 infertile women ofPCOS withinsulinresistanceparticipatedinthestudyandwere randomly allocated into 2 groups. One group was treated with tab. Myoinositol (MI) 750 mg thrice daily and other group with D-chiro-inositol (DCI) 500 mg once daily for 3 months. After 3 months, follow up fasting blood sugar, fasting insulin and HOMA-IR were measured
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 80 (actual)
- First submitted
- 10 Feb 2026
- Start date
- 1 Jun 2023
- Primary completion date
- 1 May 2024
- Lead sponsor
- Mst.Sumyara Khatun
- NCT number
- NCT07453680
What you commit to
- Study type: Interventional
- Participants enrolled: 80
- From 1 Jun 2023 to the primary completion date, 1 May 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Endocrine disorders (Diabetes mellitus, hypothyroidism, hyperprolactinemia)
Age
- Age less than 18 years and more than 35 years
Other
- BMI less than 18.5kg/ m² and more than 30 kg/ m²
- Any contraindications to MI or DCI
- Any insulin sensitizer (metformin or inositol) in the last three months
Who the study is looking for
- Diagnosed case of PCOS according to Rotterdam criteria
- Primary or secondary infertility
- Insulin resistance (HOMA-IR \>2)
Age in the registry: 18 years to 35 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Bangladesh Medical University Coordinator of this site? Confirm its status | Dhaka | Bangladesh | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.